Incorporation of osteogenic and angiogenic small interfering RNAs into chitosan sponge for bone tissue engineering by Jia S et al.
© 2014 Jia et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
International Journal of Nanomedicine 2014:9 5307–5316
International Journal of Nanomedicine Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
5307
OrIgINal research
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/IJN.S70457
Incorporation of osteogenic and angiogenic 
small interfering rNas into chitosan sponge 
for bone tissue engineering
sen Jia1,*
Xinjie Yang1,*
Wen song2,*
lei Wang1
Kaixiu Fang3
Zhiqiang hu1,4
Zihui Yang1
chun shan1 
Delin lei1 
Bin lu1
1Department of Oral and Maxillofacial 
surgery, 2Department of Prosthetic 
Dentistry, 3Department of Implant 
Dentistry, school of stomatology, 
state Key laboratory of Military 
stomatology, Fourth Military 
Medical University, Xi’an People’s 
republic of china; 4Department of 
Otorhinolaryngology, No 113  
hospital of People’s liberation army, 
Ningbo, People’s republic of china
*These authors contributed to this 
paper equally and are considered to 
be joint first authors
Abstract: Engineered bone substitutes are being extensively explored in response to growing 
demand. However, the angiogenesis that occurs during bone formation is often overlooked in 
scaffold design. In this novel study, we incorporated two small interfering RNAs (siRNAs), 
ie, small interfering RNA targets casein kinase 2 interaction protein 1 (siCkip-1) and small 
interfering RNA targets soluble VEGF receptor 1 (siFlt-1), which can promote osteogenesis and 
angiogenesis, into a chitosan sponge. This scaffold could maintain siRNAs for over 2 weeks in 
neutral phosphate-buffered saline and degraded rapidly in the presence of lysozyme. The chitosan 
sponge with siCkip-1 and siFlt-1 in vitro bioactivity was investigated using mesenchymal stem 
cells. Target genes were significantly suppressed, and osteocalcin, alkaline phosphatase, and 
vascular endothelial growth factor were significantly upregulated. Alizarin Red staining revealed 
that mineralization of the extracellular matrix was markedly enhanced by dual transfection. 
Further analysis by immunofluorescence confirmed that the siRNA-modified scaffold simulta-
neously improved the expression of osteocalcin and von Willebrand factor. In vivo testing in a 
skull critical-size defect model showed marked bone regeneration in rats treated with siCkip-1 
and siFlt-1. In conclusion, chitosan sponge containing osteogenic and angiogenic siRNAs may 
be used as a scaffold for bone regeneration. The dual siRNA concept may also be useful in the 
biofunctionalization of other materials.
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Introduction
Defective bone can be a challenging problem in a number of settings, including trauma, 
deformity, infection, and cancer.1–3 Although the host may have the ability to recover, 
bone substitutes or grafts are required when the defects are larger than a critical 
size.4 Conventional efforts to improve the osteogenic potency of bone scaffolds have 
focused mainly on immobilizing growth factors to facilitate anabolic metabolism.5,6 
Traditional tissue engineering scaffold-based implant materials focus mainly on effec-
tive and efficient osteogenesis; however, angiogenesis is another mandatory event 
during formation of bone that is often neglected in scaffold design. Angiogenesis and 
osteogenesis both require a blood supply that provides a sustentacular niche for self-
renewing osteoprogenitor cells and cytokines such as hypoxia inducible factor 17 and 
vascular endothelial growth factor (VEGF)8 during bone formation.9 The coupling 
of angiogenesis and osteogenesis is regulated by a specific vessel subtype in bone.10 
Consequently, an active blood vessel network is a prerequisite for bone regeneration. 
Combination therapies that promote both angiogenesis and osteogenesis during scaf-
fold design and manipulation are necessary.11 
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RNA interference technology has provided a promising 
method to attenuate the production of specific target proteins 
by degradation of their mRNA. This powerful tool is being 
extensively studied as a potential treatment for numerous 
diseases, including cancer,12 viral infection,13 and neurode-
generative conditions.14 In recent years, small interfering 
RNA (siRNA)-modified scaffolds have also been widely 
explored for the purpose of engineering tissue regeneration 
by guiding multilineage differentiation of mesenchymal 
stem cells (MSCs) with incorporating siRNAs.15 It is con-
sidered to be a superior therapeutic strategy due to the high 
efficiency and targeting effect. Therefore, we hypothesize 
that incorporation of siRNAs that simultaneously promote 
osteogenesis and angiogenesis into the scaffold may solve 
the problem at the gene expression level during bone regen-
eration. Each type of siRNA has a clear specific target and 
the effect would be more precise and predictable compared 
with degradation of mRNA. Targeted knockdown of casein 
kinase 2 interacting protein 1 (Ckip-1) markedly improves 
the bone phenotype both in vitro and in vivo via the bone 
morphogenetic protein-related signaling pathway.16 Mean-
while, downregulation of soluble VEGF receptor 1 (sFlt-1) 
induces angiogenesis by release of additional free VEGF.17 
Therefore, we delivered these two siRNAs simultaneously 
with the aim of promoting anabolic metabolism in defec-
tive bone.
A chitosan sponge was used as a scaffold to maintain 
and deliver the dual siRNAs. Chitosan sponges have been 
used widely as tissue engineering scaffolds in light of their 
simple fabrication, efficient aqueous absorption, and porous 
structure enabling cell penetration.18,19 These sponges can also 
release growth factors for bone regeneration in a controlled 
manner.20,21 To our knowledge, the present study is the first 
to use a chitosan sponge as a reservoir for two siRNAs. We 
analyzed this novel scaffold for bone regeneration in both in 
vitro and in vivo assays. Our results suggest that this siRNA-
modified chitosan scaffold has marked beneficial effects on 
bone regeneration.
Materials and methods
chitosan sponge preparation
The chitosan sponge was prepared according to a previous 
report.12 Initially, 100 mg of chitosan (molecular weight 
100–300 kDa, degree of deacetylation 93.37%; MP Bio-
medicals, Shanghai, People’s Republic of China) was dis-
solved overnight in 10 mL of acetic acid (2% v/v) under 
magnetic stirring. The sticky chitosan solution was then 
put into a 24-well tissue culture plate at 1 mL per well. 
The solution was frozen at a temperature below -80°C for 
4 hours, and the plate was then lyophilized for 24 hours. 
The lyophilized samples were neutralized by 1 M sodium 
hydroxide and washed with deionized water until a neutral 
pH was reached. The hydrated samples were relyophilized 
using the same protocol.
loading of lipofectamine™ 2000  
sirNa complexes
To facilitate angiogenic differentiation, siRNA tar-
get  rat  sFlt-1(siFlt-1)13  was  selected  (sense 
5′-GCGGGAGAGACUUAAACUATT-3′; antisense 
5′-UAGUUUAAGUCUCUCCCGCTT-3′;  Shanghai 
GenePharma). To enhance osteogenic differentiation, 
siRNA target rat Ckip-1(siCkip-1)14 was chosen (sense 
5′-GGACUUGGUAGCAAGGAAAdT*dT-3′; anti-
sense 5′-UUCCUUGCUACCAAGUCCdT*dT-3′; 
Shanghai GenePharma, Shanghai, People’s Republic 
of China). Universal negative control siRNA (sense 
5′-UUCUCCGAACGUGUCACGUTT-3′ and antisense 
5′-ACGUGACACGUUCGGAGAATT-3′; Shanghai 
GenePharma) was used as a negative control (siNC). Trans-
fection complexes were made by mixing 10 μL of siFlt-1 
(20 μM) and 10 μL of siCkip-1 (20 μM) with 500 μL of 
α-Minimum Essential Medium (α-MEM; Hyclone, Logan,   
UT, USA) or with 10 μL of Lipofectamine™ 2000 (Invit-
rogen, Carlsbad, CA, USA) and 500 μL of α-MEM. After 
5 minutes, the solutions were combined and added immedi-
ately to each well of the porous chitosan sponge. The siRNA-
loaded sponge was lyophilized again as described in chitosan 
sponge preparation section. The siNC was incorporated in 
a similar fashion.
Degradation profile  
for the sirNa-loaded scaffold
The siRNA-loaded sponge was immersed in either 500 μL 
of phosphate-buffered saline or phosphate-buffered saline 
containing 0.1 g/L lysozyme (Sigma-Aldrich, St Louis, MO, 
USA) for 28 days. At predetermined time points, samples of 
the solution were collected and replaced with fresh medium. 
The calibration curve was determined using standard siRNA, 
and the siRNA released in the collected samples was mea-
sured by RiboGreen (Invitrogen). The degradation rate was 
calculated by manually subtracting the siRNA released from 
the total siRNA loaded into the sponge. In addition, several 
selected sponges were freeze-dried during the degradation 
process and observed by scanning electron microscopy 
(SEM; Hitachi Ltd, Tokyo, Japan).International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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cell culture 
Primary rat bone marrow-derived MSCs were isolated and 
cultured as described elsewhere.15 The animal experiments 
were approved by the animal welfare committee of the Fourth 
Military Medical University, Xi’an, People’s Republic of 
China under the relevant laws and institutional guidelines. 
Briefly, male Sprague Dawley rats were sacrificed and 
sterilized in 75% ethanol for 15 minutes. The femurs were 
separated and bone marrow-derived MSCs were collected by 
douching with α-MEM using a syringe under sterile condi-
tions. Aspirates were centrifuged at 800 rpm for 5 minutes, 
resuspended, and maintained in α-MEM supplemented with 
10% fetal bovine serum containing 100 U/mL penicillin and 
100 μg/mL streptomycin. The medium was changed twice 
a week and passages 3–5 were used for further cell seeding. 
When 80% confluence was reached, the cells were trypsinized 
and centrifuged at 800 rpm for 5 minutes. The pellet was sus-
pended in medium to obtain a concentration of 2×105/mL, and 
1 mL was then added to the scaffold and placed in a 24-well 
plate. The scaffold was incubated for 2 hours to allow for 
adhesion, and another 1 mL of medium was then added.
cell attachment and proliferation
Cell attachment was observed by SEM 1 day after cell seeding. 
Cells were fixed in 2% glutaraldehyde for 4 hours at 4°C and 
dehydrated using graded concentrations of ethanol. The sample 
was freeze-dried, coated with platinum, and observed. After dif-
ferent incubation times, cell proliferation was measured using 
a Cell Counting Kit (CCK-8; Beyotime Institute of Biotech-
nology, Jiangsu, People’s Republic of China) according to the 
manufacturer’s instructions. In brief, CCK-8 and α-MEM were 
mixed at a ratio of 1:10 and added to each well. After incubation 
for 3 hours, the supernatant was transferred to a 96-well plate 
and absorbance was read by a plate reader at 465 nm.
colocalization of dual sirNas and cells 
Cy3-labeled siCkip-1 (siCy3) and carboxyfluorescein-
labeled siFlt-1 (siFAM) were incorporated into the chitosan 
sponge. One day after cell seeding, the sample was fixed 
with 4% paraformaldehyde (Sigma-Aldrich) for 20 minutes 
and cryosectioned by microtome in tissue freezing medium 
(Leica, Nussloch, Germany). The slices were then stained 
with 4,6-diamidino-2-phenyllindile (DAPI, Invitrogen) and 
observed by inverted fluorescence microscope (DMLRB, 
Leica). The cells from the scaffold were then trypsinized 
and centrifuged. The pellet was resuspended and checked 
by flow cytometry. Genome mean of red and green fluo-
rescence intensity was used to represent the internalization 
efficiency.
real-time quantitative polymerase chain 
reaction
Total RNA was isolated from the scaffold using a TRIzol® 
(Invitrogen)-based protocol. First, 1 μg of total RNA was 
reverse-transcribed to complementary DNA by qScript™ 
complementary DNA (cDNA) SuperMix (Quanta Bio-
sciences, Gaithersburg, MD, USA) according to the 
manufacturer’s instructions. Real-time quantitative poly-
merase chain reaction (RT-qPCR) was performed on an ABI 
7500 system with Platinum® SYBR® Green qPCR SuperMix-
UDG (Invitrogen). Normalized cDNA was amplified and 
the threshold cycle value was recorded by monitoring of 
fluorescence intensity. The relative mRNA level was calcu-
lated by the Ct value and normalized by glyceraldehyde-3-
phosphate dehydrogenase. The primer sequences are listed 
in Table 1.
Immunofluorescence analysis
The scaffold was maintained in normal medium for 3 days 
after seeding to allow for cell proliferation. Osteogenic induc-
tion was performed in an osteogenic medium container for 
14 days. The scaffold was fixed in 4% paraformaldehyde 
for 20 minutes, then cryosectioned. The specimen was 
blocked by serum for 60 minutes and permeabilized with 
Triton™ X-100 (Invitrogen) for 15 minutes. The primary 
antibodies for anti-osteocalcin and anti-von Willebrand 
Table 1 Primers used for real-time quantitative polymerase chain reaction
Gene Forward primer sequence (5′–3′) Reverse primer sequence (5′–3′)
ckip-1 gagcTTTcgggTcgaTcTgg ggcTcccTTgTcTggTcTTT
sFlt-1 TgacaTacccaaacTcgTg aaagccTcTccTacTgTcc
alp ggcTcccTTgTcTggTcTTT ggacgccgTgaagcaggTga
VegF cagcTaTTgccgTccaaTTga ccagggcTTcaTcaTTgca
OcN ggTgcagaccTagcagacacca aggTagcgccggagTcTaTTca
gaPDh caagTTcaacggcacagTca ccaTTTgaTgTTagcgggaT
Abbreviations: ckip-1, casein kinase 2 interaction protein 1; sFlt-1, soluble VegF receptor 1; alp, alkaline phosphatase; VegF, vascular endothelial growth factor; OcN, 
osteocalcin; gaDPh, glyceraldehyde-3-phosphate dehydrogenase.International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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factor was purchased from Abcam (Cambridge, MA, USA) 
and the specimens were incubated in those two antibodies 
respectively overnight. The specimens were incubated in 
fluorescein isothiocyanate-conjugated secondary antibody in 
the dark at room temperature for 1 hour. After rinsing with 
phosphate-buffered saline, the specimen was observed by 
fluorescence microscopy.
Mineralization of the extracellular matrix 
MSCs were seeded in the scaffold of a six-well plate. 
Osteogenesis-inducing medium containing 10% fetal bovine 
serum, 5 mM L-glycerophosphate, and 100 nM dexametha-
sone (Sigma-Aldrich) and 50 μg/mL ascorbic acid was used 
for 14 days when confluence reached approximately 80%. 
Cells in the scaffold were fixed in 10% formalin and incu-
bated with Alizarin Red S (Sigma-Aldrich, St Louis, MO, 
USA), 40 nM, pH 4.2) solution for 10 minutes. The samples 
were rinsed thoroughly in deionized water and imaged by 
optical microscopy.
scaffold implantation and micro-
computed tomography evaluation
In vivo bone regeneration was evaluated using a rat calvarial 
bone defect model in which the rat was anesthetized using 
1% pentobarbital, and a critical size defect of 8 mm16 was 
then created in calvarial bone followed by implantation of a 
chitosan-scaffold loaded with the different siRNAs. Three 
months later, the rats were sacrificed and the calvarial bone 
was fixed immediately in 4% paraformaldehyde. The fixed 
samples were remodeled, inserted into the chamber, and 
scanned using an Inveon micro computed tomography (CT) 
system (Siemens AG, Munich, Germany). The region of 
interest was defined as a ring with a 4 mm radius from the 
center point of the defect. The three-dimensional structure 
of the defect and the newly-formed bone was reconstructed. 
The bone volume ratio was calculated by the software pro-
vided by the manufacture and used to represent the ratio of 
new bone mass.
Van gieson’s stain
The fixed samples were washed in running water, dehydrated 
by gradient ethanol (50%–100%), and embedded in methyl-
methacrylate. Approximately 70 μm thickness sections were 
obtained by hard tissue microtome (SP1600, Leica) paral-
leled to the long axis of the calvarial bone and running water 
cooled, slices approximately 70 μm thick were harvested. 
The slices were polished and stained with 1% acid fuchsin 
and 0.5% saturated picric acid, respectively, for histological 
observation under a light microscope (Lucky Zoom, Olympus 
Corporation, Tokyo, Japan).
statistical analysis
The statistical analysis was performed using Statistical Pack-
age for the Social Sciences version 17.0 software (SPSS Inc, 
Chicago, IL, USA). Three independent experiments were 
repeated in each section and the results are presented as the 
mean ± standard error of the mean. One-way analysis of 
variance and the Student-Newman-Keuls q test were used 
to compare means. P0.05 was set as the level of statistical 
significance.
Results
characterization of sirNa-loaded 
sponges
Under SEM, the formulated chitosan sponge was seen to be a 
porous three-dimensional structure with cracks approximately 
100 μm long and 50 μm wide (Figure 1A). After loading with 
Lipofectamine/siNC, numerous Lipofectamine/siNC nano-
particles approximately 80 nm in size (Figure 1D) formed a 
larger aggregate approximately 10 μm in size (Figure 1C) and 
became attached to the sponge (Figure 1B).
The degradation profile of the sponge was determined 
after 28 days. The siRNA was released slowly from the 
sponge during the first 8 days, with over 80% still left in 
the sponge (Figure 2A) at this time, which was released 
rapidly in the following 2 days. Thereafter, the siRNA was 
released at a steady rate until the final day, with about 15% 
remaining (Figure 2A) at that time. However, the siRNA 
was released far more rapidly (within 10 days) when in 
lysozyme solution and this is attributed to digestion of 
chitosan (Figure 2A). Meanwhile, chitosan dissolved in 
phosphate-buffered saline resulted in collapse and destruction 
of the cracks (Figure 2B1–B4). The same phenomenon was 
observed to occur more rapidly in phosphate-buffered saline 
and lysozyme solution (Figure 2B5–B6).
cell attachment and proliferation
After 4 hours of attachment, the sphere-shaped cells were 
adsorbed loosely onto all of the scaffolds, with secretion 
of a small amount of extracellular matrix (Figure 3A). The 
MSCs proliferated rapidly during the first 3 days, but the rate 
of proliferation slowed thereafter. No significant difference 
in proliferation rate was observed between the sponges con-
taining siCkip-1, siFlt-1, or siNC; however, the proliferation 
rate was significantly slower than on the sponge alone after 
3 days (Figure 3B). International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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colocalization of dual sirNas and cells
The sponge was cryosectioned to observe the uptake of 
dual siRNAs one day after cell seeding. It was obvious 
that Cy3-labeled red fluorescence and FAM-labeled green 
fluorescence were colocated with DAPI-stained blue nuclei, 
implying that the dual siRNAs could simultaneously be 
internalized into cells from the scaffold (Figure 4A). The 
internalization efficiency was further confirmed by flow 
cytometry. The sponge loaded with dual siRNAs showed 
at least a 5-fold increase in fluorescence intensity in both 
the red and green channels when compared with controls, 
which was similar to the counter mono siRNA internaliza-
tion (Figure 4B).
rT-qPcr analysis
Relative gene expression was monitored by RT-qPCR. 
Sponges loaded with dual siRNAs could silence the both tar-
get genes (~80%) on day 3, which was almost the same level 
of the corresponding mono siCkip-1 or siFlt-1 transfection 
(Figure 5A). Due to the silencing of Ckip-1, mRNA for alka-
line phosphatase and osteocalcin increased by ~2.5-fold in the 
dual transfection group and by ~2-fold in the mono siCkip-1 
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group (Figure 5A). Similarly, VEGF increased markedly 
(by ~3.5-fold) in the dual transfection group and by ~2.5-fold 
in the mono siFlt-1 transfection group (Figure 5A). One week 
later, the target genes recovered to ~50% in the sponge con-
taining the dual siRNAs (Figure 5B). Alkaline phosphatase 
and osteocalcin increased by ~5.5-fold in the dual transfection 
group and by ~3.5-fold in the mono siCkip-1 transfection 
group (Figure 5B). Meanwhile, VEGF increased by~5-
fold in the dual transfection group and by ~4.5-fold in the 
mono siFlt-1 transfection group (Figure 5B). Interestingly, 
VEGF in the siCkip-1 mono transfection group increased 
by ~2.5-fold and alkaline phosphatase and osteocalcin   
by ~2.5-fold in the siFlt-1 mono transfection group, suggesting 
that crosstalk may exist (Figure 5B). This silencing effect 
disappeared after incubation for 2 weeks; however, alkaline 
phosphatase, osteocalcin, and VEGF expression was still 
over 3-fold higher in the dual siRNA group while the counter 
mono transfection groups were ~2-fold higher (Figure 5C). 
VEGF, alkaline phosphatase, and osteocalcin were also 
increased in the siCkip-1 and siFlt-1 mono transfection 
groups (Figure 5C).
Mineralization in the extracellular matrix 
The osteoblast phenotype was confirmed by Alizarin Red 
staining for matrix mineralization. Osteogenic differentiation 
of MSCs was enhanced on either siCkip-1 or siFlt-1 loaded 
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sponge compared with siNC or blank sponge (Figure 6). 
However, sponge loaded with both siCkip-1 and siFlt-1 
could further increase the osteogenic differentiation when 
compared with the group loaded with siCkip-1 or siFlt-1 
(Figure 6).
Immunofluorescence assay
The in vitro bone anabolic potency of the scaffold was deter-
mined by immunofluorescence staining. Osteocalcin was 
abundantly expressed on the dual siRNA-loaded scaffold but 
remained at a low level in the other scaffolds (Figure 6). In 
addition, the novel vascularization protein, von Willebrand 
factor, was also markedly enhanced on the dual siRNA-
modified scaffold (Figure 6). As expected, osteocalcin was 
also upregulated in the mono siCkip-1 transfection group, as 
was von Willebrand factor in the mono siFlt-1 transfection 
group (Figure 6).
Bone regeneration in the rat skull 
defect model
New bone formation in the defect area was scanned by 
microCT and the bone volume ratio in the region of interest 
was taken to represent newly generated bone. The sponge 
loaded with dual siRNAs was able to promote significant 
defect restoration when compared with the other groups 
(Figure 7A and C). Mono siCkip-1 transfection could also 
increase new bone formation when compared with the siNC 
or blank sponge. However, mono siCkip-1 transfection 
improved new bone formation much less in comparison 
with dual transfection (Figure 7A and C). The sectioned 
sample was stained according to Van Gieson’s protocol 
after ultrahard slicing. As with microCT scanning, the two-
dimensional new bone area within the defect was largest in 
the dual transfection group; mono siCkip-1 also promoted 
more new bone generation in comparison with the siNC or 
blank sponge (Figure 7B and D).
Discussion
In this study, siCkip-1 and siFlt-1 were coimmobilized into 
chitosan to form a novel scaffold. These two siRNAs could 
be maintained in this scaffold for over 2 weeks and were able 
to colocate around seeded MSCs. In vivo and in vitro tests 
demonstrated that chitosan sponge containing osteogenic 
and angiogenic siRNAs promoted significant regeneration 
of bone. The present study may provide a new treatment 
strategy for bone defect.
Dual delivery of two therapeutic molecules can have 
simultaneous functional effects, with a synergistic outcome. 
Qu et al17 used basic fibroblast growth factor, which has 
activity in both osteogenesis and angiogenesis, to treat bone 
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MSCs by seeding this factor into a nanohydroxyapatite/
polyamide66 (n-HA/PA66) composite scaffold to mimic 
natural osteogenesis.17 B-cell lymphoma-extra large siRNA 
and   doxorubicin have been codelivered for a synergistic anti-
cancer effect.18 Cao et al have also synthesized and assembled 
biodegradable nanocarriers for dual delivery of siRNA and 
chemotherapeutic drugs into hepatic cancer cells.19 Moreover, 
siRNAs have been transfected to modulate the T-cell response 
by dual mode.20 Unfortunately, dual delivery of two siRNAs 
in bone tissue engineering is still seldom validated.
In our study, siRNAs promoting osteogenesis and angio-
genesis were codelivered by Lipofectamine derived from 
chitosan sponge. Chitosan is an inexpensive and nontoxic 
polymer which has been extensively used as a drug carrier 
system.21 Chitosan sponge is a porous and plastic material 
compared with solid bone substitutes, so it is favorable for 
both drug loading and irregular bone defects restoration. 
Therefore, it may be more suitable for craniomaxillofa-
cial defects regeneration since most of the bones here are 
curved and complicated.22 In addition, chitosan sponge can 
be synthesized without additional reagents that could have 
unwanted effects. For these reasons, chitosan sponge was 
used as both a drug reservoir and regeneration material in 
our study.
Chitosan sponge has been used as a carrier enabling 
sustained drug release.21 Our results confirmed that two 
siRNAs can have a superimposed action when cotransfected 
into MSCs from the sponge. In the surface characterization 
study, numerous Lipofectamine/siRNA particles aggregated 
together after lyophilization;23 however, the particles behaved 
very differently when compared with those from the direct 
measurement from aqueous solution.23 This aggregation 
might possibly be ascribed to the use of a lyophilization 
process without nonionic lyoprotectants.24 The siRNA release 
from the sponge could persist for a relatively long duration, 
which could probably acquire prolonged gene silenc  e effect. 
In addition, the RT-qPCR data showed that the target genes 
were suppressed for at least 1 week. The growth rates of 
MSCs in the sponge + siCkip-1, siFlt-1, and sponge + siNC 
groups were not significantly different; however, both of 
them significantly lower than the sponge alone, indicating 
that the suppression may have originated from Lipofectamine 
and it was considered as its main drawback.22,25,26 Colocaliza-
tion observed by fluorescence microscope and quantitative 
data with flow cytometer assay showed high transfection 
efficiency in MSCs, which is in agreement with a previous 
report,22 and suggests that Lipofectamine could be used to 
deliver two siRNAs simultaneously. These results indicate 
that the chitosan sponge can be used to deliver dual siRNAs 
in a sustainable manner.
siCkip-1 is a well-documented anabolic molecule in 
bone14 and the increased VEGF caused by siFlt-1 might also 
improve bone formation.27 Similarly, VEGF expression was 
improved after silencing of Ckip-1. Therefore, knockdown of 
Ckip-1 or sFlt-1 alone was able to increase the expression of 
osteogenic genes and new bone regeneration to some degree. 
However, when they were delivered together, osteogenic dif-
ferentiation was markedly improved both in vitro and in vivo, 
indicating that the angiogenic effect of siFlt-1 could further 
enhance the osteogenic effect of siCkip-1. Taken together, 
manipulating osteogenesis and angiogenesis simultaneously 
during bone tissue engineering may provide a more powerful 
efficiency.28
Conclusion
siRNA-modified chitosan sponges could maintain siRNA for 
a longer term without losing its efficacy. Chitosan sponges 
loaded with both siCkip-1 and siFlt-1 had superimposed 
activity, resulting in a high degree of colocalization with 
cells and simultaneous enhancement of both osteogenesis and 
angiogenesis in vitro. Our in vitro and in vivo studies show 
that this scaffold is able to promote new bone regeneration. 
This dual siRNA-modified chitosan scaffold could potentially 
be used for restoration of healthy bone.
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